NCT00332137View on ClinicalTrials.gov

Effects of Tolterodine, a Non-Specific Muscarinic Antagonist, on Gastrointestinal Transit in Healthy Subjects

PHASE2CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions

Health

Interventions

DRUG

Tolterodine

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Mayo Clinic

OTHER